FDA updates labeling for OLANZAPINE FDA Approval Dec. 08, 2025, 09:39 UTC Labeling changes approved for TORRENT PHARMS LTD. Active ingredient: OLANZAPINE. Decision date: 12/02/2025 Full text
There are no comments here yet...